How many insider trades does FilingIQ track for BCAX?

FilingIQ tracks 160 Form 4 insider transactions for BCAX (Bicara Therapeutics Inc.), covering filings from Sep 16, 2024 onwards. 13 of those are dated within the last 90 days.

Are BCAX insiders net buyers or net sellers?

Across the full Form 4 history for BCAX, 5 transactions (3%) were open-market purchases and 76 (48%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BCAX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is BCAX in?

Bicara Therapeutics Inc. (BCAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $780.10M.

BCAX insider trading

Healthcare

Bicara Therapeutics Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

160

Last 90 days

Buys / sells

3% / 48%

Market cap

$780.10M

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Company website: www.bicara.com

BCAX insider activity at a glance

FilingIQ tracks 160 insider transactions for BCAX in filings since Sep 16, 2024. The most recent transaction is dated Sep 8, 2026.

Across the full history, 5 open-market purchases and 76 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BCAX insider trades is 49.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BCAX trades on FilingIQ Raw filings on SEC EDGAR

Latest BCAX Form 4 filings

Cohlhepp Ryan President, COO & Interim CEO

SM Sep 10, 2026

Larson Jennifer Chief Financial Officer

A Aug 14, 2026

Hyep Ivan Chief Financial Officer

SM Aug 12, 2026

Mazumdar Claire Chief Executive Officer

SM Aug 12, 2026

Cohlhepp Ryan President and COO

Mazumdar Claire Chief Executive Officer

SM Jul 14, 2026

Cohlhepp Ryan President and COO

SM Jul 10, 2026

Hyep Ivan Chief Financial Officer

SM Jul 10, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for BCAX?: FilingIQ tracks 160 Form 4 insider transactions for BCAX (Bicara Therapeutics Inc.), covering filings from Sep 16, 2024 onwards. 13 of those are dated within the last 90 days.
Are BCAX insiders net buyers or net sellers?: Across the full Form 4 history for BCAX, 5 transactions (3%) were open-market purchases and 76 (48%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BCAX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is BCAX in?: Bicara Therapeutics Inc. (BCAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $780.10M.

Methodology & sources

Every BCAX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.